Study of Tazemetostat in Lymphoid Malignancies
Clinical trial NCT05983965 · TERMINATED
Trial details
- NCT number
- NCT05983965
- Sponsor
- University of Alabama at Birmingham
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-05
- Primary completion
- 2026-03-06
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.